Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: September 9, 2026 at 9:54 PM UTC
| NCT Number | NCT07625215 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | PHASE2 |
| Target Enrollment | 360 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | September 9, 2026 (21 hours ago) |
As of September 9, 2026: Clinical trial NCT07625215 is currently recruiting participants. This phase2 study for atrial fibrillation is actively seeking new participants at 7 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07625215 is actively recruiting participants as of September 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07625215 was last updated 21 hours ago (September 9, 2026). HelloStudys verifies this status automatically.